Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc, Charles Pfizer and Co IncfiledCriticalPfizer Inc
Priority to ES0230853ApriorityCriticalpatent/ES230853A1/es
Publication of ES230853A1publicationCriticalpatent/ES230853A1/es
Procedimiento para la oxidación nuclear de un compuesto 3-ceto símbolo incremento elevado a 4- esteroídico que tenga de 18 a 21 átomos en el esqueleto carbonado, cuyo procedimiento comprende el contacto del esteroide con la actividad oxidante de un organismo del género Nocardia.
ES0230853A1956-09-111956-09-11UN PROCEDIMIENTO PARA LA OXIDACIoN NUCLEAR DE UN COMPUESTO ESTEROiDICO
ExpiredES230853A1
(es)